EyePoint (EYPT) Current Deferred Revenue (2011 - 2025)

EyePoint (EYPT) reported Current Deferred Revenue of $5.1 million for Q1 2025, down 86.67% on a YoY basis from $38.4 million in Q1 2024, and down 71.24% sequentially from $17.8 million in Q4 2024.

EyePoint (EYPT) Current Deferred Revenue (2011 - 2025) Analysis & Trends

EyePoint (EYPT) has 15 years of Current Deferred Revenue data on file, last reported at $5.1 million in Q1 2025.

  • For the quarter ending Q1 2025, Current Deferred Revenue fell 86.67% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2025 stood at $5.1 million (down 86.67% YoY), and the FY2024 full-year result was $17.8 million, down 53.92% from the prior year.
  • Current Deferred Revenue eased to $5.1 million in Q1 2025, from $17.8 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $42.1 million in Q2 2023 to a low of $973000.0 in Q1 2021.
  • A 5-year average of $14.8 million and a median of $1.2 million in 2023 frame the typical range for Current Deferred Revenue.
  • Across the five-year window, Current Deferred Revenue soared 3601.32% in 2023 and plunged 86.67% in 2025, its largest moves.
  • Tracing EYPT's Current Deferred Revenue over 5 years: stood at $1.1 million in 2021, then gained by 12.72% to $1.2 million in 2022, then jumped by 3102.66% to $38.6 million in 2023, then tumbled by 53.92% to $17.8 million in 2024, then sank by 71.24% to $5.1 million in 2025.
  • Business Quant data shows EYPT's Current Deferred Revenue at $5.1 million in Q1 2025, $17.8 million in Q4 2024, and $26.0 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00

Historic Data

Download Data
DateValue
Mar 31, 2025 5.12 Mn
Dec 31, 2024 17.78 Mn
Sep 30, 2024 26.00 Mn
Jun 30, 2024 33.34 Mn
Mar 31, 2024 38.38 Mn
Dec 31, 2023 38.59 Mn
Sep 30, 2023 39.84 Mn
Jun 30, 2023 42.08 Mn
Mar 31, 2023 1.24 Mn
Dec 31, 2022 1.21 Mn
Sep 30, 2022 1.17 Mn
Jun 30, 2022 1.14 Mn
Mar 31, 2022 1.10 Mn
Dec 31, 2021 1.07 Mn
Sep 30, 2021 1.04 Mn
Jun 30, 2021 1.01 Mn
Mar 31, 2021 973,000.00
Dec 31, 2020 945,000.00
Sep 30, 2020 300,000.00
Mar 31, 2020 30,000.00